Brandon D. Smith

Chief Restructuring Officer, Impel Neuropharma (United States).

Companies

Impel Neuropharma (United States)Chief Restructuring Officer Dec 26, 2023 to Dec 26, 2023¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImpel Neuropharma (United States), Chief Restructuring Officer